Advertisement
Advertisement
ALMR
Alamar Biosciences, Inc. Common Stock
25.12
USDSponsored
-0.03
-0.12%
Jul 22, 15:59 UTC -4
Closed
Pre-Market
25.09
-0.03
-0.10%
Alamar Biosciences, Inc. Common Stock Profile
Alamar Biosciences, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
1.74B
Enterprise Value
1.75B
Enterprise Value/EBITDA(ttm)
-157.45
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
--
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
--
Operating Margin(ttm)
--
Profit Margin(ttm)
--
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
--
Return on Assets(ttm)
--
Income Statement
Revenue(ttm)
26.04M
Revenue Per Share(ttm)
0.38
Gross Profit(ttm)
14.46M
EBITDA(ttm)3
-11.11M
Net Income Available to Common(ttm)
-21.32M
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
--
52-Week Change
--
S&P 500 52-Week Change
17.93%
S&P 500 Member
No
Stock Optionable
No
Total Shares Outstanding1
69.31M
Dividend Yield
--
Float4
--
% Held by Insiders
--
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
64.59M
Total Cash Per Share(mrq)
0.93
Total Debt(mrq)
74.97M
Total Debt/Equity(mrq)
--
Current Ratio(mrq)
--
Quick Ratio(mrq)
--
Book Value Per Share(mrq)
--
Cash Flow
Operating Cash Flow Per Share(ytd)
--
Free Cash Flow(ytd)
--
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement